Semaglutide: A Promising Ally Against Alzheimer’s?
In a groundbreaking study, researchers at Case Western Reserve School of Medicine have identified a potential new benefit of semaglutide, a widely used diabetes and weight-loss drug. According to their findings, semaglutide may significantly reduce the risk of Alzheimer’s disease in individuals with type 2 diabetes (T2D), outperforming seven other anti-diabetic medications.
Alzheimer’s disease, a devastating brain disorder that erodes memory and cognitive abilities, affects nearly 7 million Americans aged 65 and older, as reported by the Alzheimer’s Association. Alarmingly, it claims more lives annually than breast and prostate cancer combined.
Published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, the study suggests that T2D patients taking semaglutide had a markedly lower risk of developing Alzheimer’s disease. This trend was consistent across various subgroups, regardless of obesity status, gender, or age.
Semaglutide, a glucagon-like peptide receptor (GLP-1R) agonist, is the active ingredient in popular medications like Wegovy and Ozempic. It works by reducing hunger and regulating blood sugar levels in T2D patients.
Under the leadership of Rong Xu, a professor of biomedical informatics, the research team analyzed three years of electronic health records from nearly one million U.S. patients with T2D. Their statistical approach, which mimicked a randomized clinical trial, revealed that patients prescribed semaglutide had a significantly lower risk of Alzheimer’s compared to those on other anti-diabetic medications.
According to the CDC, Alzheimer’s disease results in approximately 120,000 deaths annually, ranking as the seventh-leading cause of death in the United States.
“This new study provides real-world evidence for semaglutide’s potential impact on Alzheimer’s disease,” Xu stated. “While preclinical research has hinted at its protective effects against neurodegeneration and neuroinflammation, our findings suggest the need for further exploration through randomized clinical trials.”
Despite these promising results, the study’s limitations prevent researchers from drawing definitive causal conclusions. Xu emphasized the importance of continued research into semaglutide’s potential as a treatment for this debilitating condition, encouraging further investigation into alternative drugs.
For more information, please contact Patty Zamora at [email protected].
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
Many Floridians are discovering after major hurricanes that what they assumed was covered by their insurance simply isn’t. With more than 100,000 claims denied or closed without payment and widespread confusion over gaps like flood versus hurricane coverage, experts warn that the fine print can hit harder than the storm itself. As premiums rise and policies grow more complex, understanding what’s actually protected has become essential for homeowners and real estate professionals alike.
A new report from Zillow shows the U.S. just experienced its strongest October housing market since 2021, with inventory rising, affordability improving, and both new listings and pending sales up 5% year-over-year. Nineteen major markets now favor buyers—nine more than last year—as mortgage rates ease, inventory rebounds, and home values level off. For real estate professionals, especially in Florida, these shifts signal a market gaining momentum heading into 2025 and beyond.
Commercial real estate is heading into 2026 with major shifts in policy, technology, investment flows, and market fundamentals. From tightening capital sources and AI-driven decision-making to nationwide housing shortages and a looming wave of maturing debt, professionals across real estate, finance, insurance, and development must adapt quickly. These trends will shape opportunities, risks, and required skills in the year ahead—making strategic education and licensing upgrades more important than ever.
A major cyberattack on real‑estate data giant SitusAMC has triggered emergency responses across Wall Street, exposing sensitive loan records and legal documents tied to major banks like JPMorgan and Citigroup. While operations have been restored, the breach highlights critical weaknesses in third‑party vendors that support the nation’s real‑estate and mortgage infrastructure. Federal investigators and financial institutions are now racing to assess the fallout as experts warn of long‑term risks to the digital systems underpinning multi‑trillion‑dollar lending markets.
Australia’s commercial real estate sector is undergoing a major long‑term shift driven by hybrid work, booming logistics demand, sustainability priorities and evolving global capital flows. With the market projected to grow from USD 11.96 billion in 2024 to USD 21.03 billion by 2033, the biggest opportunities are emerging in industrial assets, ESG‑certified buildings, flexible workspaces and adaptive reuse projects. These trends echo changes developing in the U.S.—including Florida—making Australia a valuable case study for professionals watching the future of commercial real estate.
A new wave of chat‑driven AI tools is transforming how agents market properties by letting them edit listing photos simply by describing what they want changed. From removing clutter to adjusting lighting or staging entire rooms, professionals can now showcase a unit’s full potential long before it’s camera‑ready. This technology boosts efficiency for property managers, enhances buyer engagement through interactive visuals, and underscores the importance of transparency as AI becomes a core part of real estate marketing.
